Section 17-8311. SUPERVISED PRACTICE

8311.1 An applicant for a pharmaceutical detailer license may engage in the supervised practice of pharmaceutical detailing under the supervision of a licensed pharmaceutical detailer for a period not to exceed sixty (60) days under the following conditions:

 

(a) The applicant has an initial application for licensure pending before the

Board;

(b) Has received a supervised practice letter from the Board; and

 

(c) Has not previously received a supervised practice letter from the Board.

 

8311.2The supervising pharmaceutical detailer shall be fully responsible for the

supervised practice of the supervisee during the period of supervision, and is

subject to disciplinary action for any violation of the Act or this chapter by the

person being supervised.

 

8311.3A supervisee shall be subject to all applicable provisions of the Act and

this chapter.

 

8311.4 If the Board finds that a person practicing under supervision has violated the Act

or this title, the Board may, in addition to any other disciplinary actions permitted

by the Act, deny, revoke, suspend, or restrict the privilege of the supervisee to

practice.

 

authority

Pursuant to the District of Columbia Health Occupations Revision Act of 1985, effective March 25, 1986 (D.C. Law 6-99; D.C. Official Code § 3-1203.02(14)), Mayor's Order 98-140, dated August 20, 1998, the SafeRx Amendment Act of 2008, effective March 26, 2008 (D.C. Law 17-0131; 55 DCR 4462, published on April 25, 2008) (the Act), and Mayor’s Order 2008-94, dated July 3, 2008.

source

Notice of Final Rulemaking published at 56 DCR 2951 (April 17, 2009).